Our latest study, published in Neurobiology of Aging, investigates the role of the novel peptide T14 in age-dependent behaviours using female mice models. The findings highlight significant variations in T14 levels with age, shedding light on potential mechanisms...
Our study demonstrates that T14, a 14-mer peptide associated with Alzheimer’s disease, impairs autophagy via the mammalian target of rapamycin complex 1, contributing to the progression of the pathology. This finding adds a new layer of understanding to how T14...
Our team has demonstrated that oxidative stress, triggered by high glucose, increases T14 peptide levels in vitro and reduces cell viability. The cyclic form of T14, NBP14, blocked these toxic effects, suggesting its potential as a therapeutic agent. These findings...
NEURO-BIO LTD AND WORLDWIDE EXPERTS ON AD PUBLISH A NOVEL PERSPECTIVE IN ALZHEIMER’S & DEMENTIA: THE JOURNAL OF THE ALZHEIMER’S ASSOCIATION. Evidence for a novel neuronal mechanism driving Alzheimer’s disease, upstream of amyloid (Link to the paper) An...
Aging US published Neuro-Bio’s paper in collaboration with Unilever on June 28, 2023, entitled, “A novel peptide ‘T14’ reflects age and photo-aging in human skin.” Click here to read the full paper. A video summary is able to watch below....
We are delighted to announce a press release between Unilever and Neuro-Bio sharing the following : Unilever and Neuro-Bio discover a novel marker of skin aging of possible relevance to Alzheimer’s disease. In a pioneering discovery, scientists at Unilever and...